Skip to main content
Skip to navigation
How To
About NCBI Accesskeys
Sign in to NCBI
US National Library of Medicine National Institutes of Health
Search databaseSearch termSearch
Result Filters
AbstractSend to:
Crit Rev Toxicol. 2008;38 Suppl 1:1-47. doi: 10.1080/10408440802276167.
Update of potency factors for asbestos-related lung cancer and mesothelioma.
Berman DW1, Crump KS.
Author information
The most recent update of the U.S. Environmental Protection Agency (EPA) health assessment document for asbestos (Nicholson, 1986, referred to as “the EPA 1986 update”) is now 20 years old. That document contains estimates of “potency factors” for asbestos in causing lung cancer (K(L)’s) and mesothelioma (K(M)’s) derived by fitting mathematical models to data from studies of occupational cohorts. The present paper provides a parallel analysis that incorporates data from studies published since the EPA 1986 update. The EPA lung cancer model assumes that the relative risk varies linearly with cumulative exposure lagged 10 years. This implies that the relative risk remains constant after 10 years from last exposure. The EPA mesothelioma model predicts that the mortality rate from mesothelioma increases linearly with the intensity of exposure and, for a given intensity, increases indefinitely after exposure ceases, approximately as the square of time since first exposure lagged 10 years. These assumptions were evaluated using raw data from cohorts where exposures were principally to chrysotile (South Carolina textile workers, Hein et al., 2007; mesothelioma only data from Quebec miners and millers, Liddell et al., 1997) and crocidolite (Wittenoom Gorge, Australia miners and millers, Berry et al., 2004) and using published data from a cohort exposed to amosite (Paterson, NJ, insulation manufacturers, Seidman et al., 1986). Although the linear EPA model generally provided a good description of exposure response for lung cancer, in some cases it did so only by estimating a large background risk relative to the comparison population. Some of these relative risks seem too large to be due to differences in smoking rates and are probably due at least in part to errors in exposure estimates. There was some equivocal evidence that the relative risk decreased with increasing time since last exposure in the Wittenoom cohort, but none either in the South Carolina cohort up to 50 years from last exposure or in the New Jersey cohort up to 35 years from last exposure. The mesothelioma model provided good descriptions of the observed patterns of mortality after exposure ends, with no evidence that risk increases with long times since last exposure at rates that vary from that predicted by the model (i.e., with the square of time). In particular, the model adequately described the mortality rate in Quebec chrysotile miners and millers up through >50 years from last exposure. There was statistically significant evidence in both the Wittenoom and Quebec cohorts that the exposure intensity-response is supralinear(1) rather than linear. The best-fitting models predicted that the mortality rate varies as [intensity](0.47) for Wittenoom and as [intensity](0.19) for Quebec and, in both cases, the exponent was significantly less than 1 (p or =3:1. Moreover, PCM does not distinguish between asbestos and nonasbestos particles. One possible reason for the discrepancies between the K(L)’s and K(M)’s from different studies is that the category of structures included in PCM counts does not correspond closely to biological activity. In the accompanying article (Berman and Crump, 2008) the K(L)’s and K(M)’s and related uncertainty bounds obtained in this article are paired with fiber size distributions from the literature obtained using transmission electron microscopy (TEM). The resulting database is used to define K(L)’s and K(M)’s that depend on both the size (e.g., length and width) and mineralogical type (e.g., chrysotile or crocidolite) of an asbestos structure. An analysis is conducted to determine how well different K(L) and K(M) definitions are able to reconcile the discrepancies observed herein among values obtained from different environments.
PMID: 18671157 [PubMed – indexed for MEDLINE]
Share on FacebookShare on TwitterShare on Google+
Publication Types, MeSH Terms, Substances
LinkOut – more resources
PubMed Commons home
PubMed Commons

How to join PubMed Commons
Supplemental Content
Full text links
Icon for Informa Healthcare
Save items
Add to Favorites
View more options
Similar articles
A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type.
[Crit Rev Toxicol. 2008]
Review Comparing milled fiber, Quebec ore, and textile factory dust: has another piece of the asbestos puzzle fallen into place?
[Crit Rev Toxicol. 2010]
The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure.
[Ann Occup Hyg. 2000]
Review An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments.
[Regul Toxicol Pharmacol. 2008]
Review An evaluation of reported no-effect chrysotile asbestos exposures for lung cancer and mesothelioma.
[Crit Rev Toxicol. 2008]
See reviews…
See all…
Related information
Articles frequently viewed together
PubChem Substance (MeSH Keyword)
Cited in PMC
Recent Activity
ClearTurn Off
Update of potency factors for asbestos-related lung cancer and mesothelioma.
Malignant mesothelioma: biology, diagnosis and therapeutic approaches.
Crystallization of Doc and the Phd-Doc toxin-antitoxin complex.
Applications of Molecular Biology to Cancer Prevention and Treatment – The Cell
Review of endovascular brachytherapy physics for prevention of restenosis.
See more…
You are here: NCBI > Literature > PubMedWrite to the Help Desk
Simple NCBI Directory
NCBI Education
NCBI Help Manual
NCBI Handbook
Training & Tutorials
Chemicals & Bioassays
Data & Software
Domains & Structures
Genes & Expression
Genetics & Medicine
Genomes & Maps
Sequence Analysis
Training & Tutorials
PubMed Central
PubMed Health
Genetic Testing Registry
PubMed Health
Reference Sequences
Gene Expression Omnibus
Map Viewer
Human Genome
Mouse Genome
Influenza Virus
Sequence Read Archive
About NCBI
Research at NCBI
NCBI on Facebook
NCBI on Twitter
NCBI on YouTube
Copyright | Disclaimer | Privacy | Browsers | Accessibility | Contact
National Center for Biotechnology Information, U.S. National Library of Medicine
8600 Rockville Pike, Bethesda MD, 20894 USA


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s